Dublin-based Mallinckrodt agrees to pay $14 a share for Cadence Pharmaceuticals.An Irish pharmaceutical company agreed to acquire Cadence Pharmaceuticals Inc. in San Diego for about $1.3 billion in an effort to boost its specialty drugs portfolio.
By Stuart Pfeifer, Los Angeles Times: Business
Tue, 02/11/2014 - 6:26pm
Dublin-based Mallinckrodt agrees to pay $14 a share for Cadence Pharmaceuticals.An Irish pharmaceutical company agreed to acquire Cadence Pharmaceuticals Inc. in San Diego for about $1.3 billion in an effort to boost its specialty drugs portfolio.